Cargando…
Anti-HMGCR Myopathy
Anti-HMGCR myopathy was first recognized and characterized in patients with a history of statin exposure and immune-mediated necrotizing myopathy. After the discovery of anti-HMGCR autoantibodies, several international groups identified and characterized more patients, expanding the phenotypic spect...
Autores principales: | Mohassel, Payam, Mammen, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5836404/ https://www.ncbi.nlm.nih.gov/pubmed/29480216 http://dx.doi.org/10.3233/JND-170282 |
Ejemplares similares
-
Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy
por: Ramanathan, Sudarshini, et al.
Publicado: (2015) -
Myopathy with anti-HMGCR antibodies: Perimysium and myofiber pathology
por: Alshehri, Ali, et al.
Publicado: (2015) -
Clinical and Radiological Features of Korean Patients With Anti-HMGCR Myopathy
por: Oh, Eun Kyoung, et al.
Publicado: (2023) -
Anti-HMGCR Myopathy without Exposure to Statins: A Case Report
por: Ferriz Vivancos, Jorge, et al.
Publicado: (2022)